Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

OrderlyMeds vs Synergy Rx

OrderlyMeds
Graded #78

Lower grade

vs+3.799999999999997
Synergy Rx
Graded #41

Higher grade

The verdict

Synergy Rx takes it — 76.2/100 to 72.4/100.

Synergy Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Brand Wegovy, Ozempic or Mounjaro when clinically appropriate, with unlimited round-the-clock clinical contact.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueOrderlyMeds +30
92
62
Dose & formulationSynergy Rx +24
64
88
Clinical oversightSynergy Rx +10
82
92
Labs & monitoringSynergy Rx +13
53
66
FulfillmentSynergy Rx +13
65
78
Contract termsSynergy Rx +13
55
68
OrderlyMeds · left barSynergy Rx · right bar

The numbers

MetricOrderlyMedsSynergy Rx
WeighScore72.4/10076.2/100
GradeCC
Scorecard rank#78#41
Semaglutide$74/mo (starting dose, 2-mo starter plan, new patients only, compounded)From $199/mo
Tirzepatide$299/mo (compounded)From $349/mo
CoverageCoverage not publishedNot disclosed
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
OrderlyMeds

Graded #78 · C

Strengths

  • The starter rate and the standing rate are both published, so the step-up is visible before signing up
  • No membership fees and no hidden costs, stated as such
  • The dose ladder is published: four weeks at 0.25 mg then four weeks at 0.5 mg
  • Brand-name routes are priced openly, at retail

Where it loses points

  • The $74 rate is a two-month starter plan billed as $149 up front, and it is open only to patients new to GLP-1 medication; the standing monthly rate is $149
  • Tirzepatide has no equivalent standing discount — $299/mo is the ongoing rate
  • Brand-name routes are priced at retail: Wegovy $1,839 and Zepbound $1,498
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
Synergy Rx

Graded #41 · C

Strengths

  • Prescribes FDA-approved brand Wegovy, Ozempic and Mounjaro when clinically appropriate
  • Unlimited appointments, unlimited messaging and 24/7 access to a dedicated clinical team
  • $100 welcome credit at checkout, and FSA/HSA eligible

Where it loses points

  • Publishes no GLP-1 price anywhere on its own site
  • At $349/mo tirzepatide sits roughly $100 above the compounded median we track
  • Does not publish which states it serves
  • No published cancellation or refund terms

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard